Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
A Phase I Study of Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Other Hematologic Malignancies
Background: Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RAS genes. These mutations can cause the …
Malignancy, HematologicNeoplasms, HematologicNeoplasms, Hematopoietic+8 more
Estimated
~$10 – $5,625
National Cancer Institute (NCI)NCT06904066
Phase 2
A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Leukemia or Lymphoma
This study will evaluate whether processing blood stem cell transplants using an investigational device (the CliniMACS system) results in less complications fo…
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute
Estimated
~$10 – $7,500
Guenther KoehneNCT05565105
Phase 1
A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia and Other Selected Hematologic Malignancies, With and Without Mixed Lineage Leukemia (MLL) Rearrangement or Nucleophosmin 1 (NPM1) Mutation (Horizen-1)
A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in patients with acute leukemia.
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, AcuteMultiple Myeloma+1 more
Estimated
~$10 – $8,750
Sumitomo Pharma America, Inc.NCT04988555